Acute isolated ophthalmoplegia with anti-GQ1b antibodies

Andrea Rigamonti, Giuseppe Lauria, Marco Longoni, Lorenzo Stanzani, Elio Agostoni

Research output: Contribution to journalArticle

Abstract

Ophthalmoplegia without ataxia, areflexia or both has been designated as atypical Miller Fisher syndrome (MFS) or acute ophthalmoplegia (AO). This entity, first reported by Chiba et al. is associated with anti-GQ1b IgG antibodies.We report a patient with isolated acute ophthalmoplegia with high titer of anti-GQ1b IgG antibody activity in the acute phase in whom treatment with intravenous immunoglobulin (IVIg) led to the clinical recovery and the decrease in antibody titer.

Original languageEnglish
Pages (from-to)681-682
Number of pages2
JournalNeurological Sciences
Volume32
Issue number4
DOIs
Publication statusPublished - Aug 2011

Fingerprint

Ophthalmoplegia
Anti-Idiotypic Antibodies
Antibodies
Miller Fisher Syndrome
Intravenous Immunoglobulins
Ataxia
anti-IgG
Therapeutics

Keywords

  • Acute ophthalmoplegia
  • GQ1b IgG antibodies
  • Intravenous immunoglobulin
  • Miller Fisher syndrome

ASJC Scopus subject areas

  • Clinical Neurology
  • Psychiatry and Mental health
  • Dermatology

Cite this

Acute isolated ophthalmoplegia with anti-GQ1b antibodies. / Rigamonti, Andrea; Lauria, Giuseppe; Longoni, Marco; Stanzani, Lorenzo; Agostoni, Elio.

In: Neurological Sciences, Vol. 32, No. 4, 08.2011, p. 681-682.

Research output: Contribution to journalArticle

Rigamonti, A, Lauria, G, Longoni, M, Stanzani, L & Agostoni, E 2011, 'Acute isolated ophthalmoplegia with anti-GQ1b antibodies', Neurological Sciences, vol. 32, no. 4, pp. 681-682. https://doi.org/10.1007/s10072-011-0492-9
Rigamonti, Andrea ; Lauria, Giuseppe ; Longoni, Marco ; Stanzani, Lorenzo ; Agostoni, Elio. / Acute isolated ophthalmoplegia with anti-GQ1b antibodies. In: Neurological Sciences. 2011 ; Vol. 32, No. 4. pp. 681-682.
@article{c8109e3a61404b4a84328a2022a01650,
title = "Acute isolated ophthalmoplegia with anti-GQ1b antibodies",
abstract = "Ophthalmoplegia without ataxia, areflexia or both has been designated as atypical Miller Fisher syndrome (MFS) or acute ophthalmoplegia (AO). This entity, first reported by Chiba et al. is associated with anti-GQ1b IgG antibodies.We report a patient with isolated acute ophthalmoplegia with high titer of anti-GQ1b IgG antibody activity in the acute phase in whom treatment with intravenous immunoglobulin (IVIg) led to the clinical recovery and the decrease in antibody titer.",
keywords = "Acute ophthalmoplegia, GQ1b IgG antibodies, Intravenous immunoglobulin, Miller Fisher syndrome",
author = "Andrea Rigamonti and Giuseppe Lauria and Marco Longoni and Lorenzo Stanzani and Elio Agostoni",
year = "2011",
month = "8",
doi = "10.1007/s10072-011-0492-9",
language = "English",
volume = "32",
pages = "681--682",
journal = "Neurological Sciences",
issn = "1590-1874",
publisher = "Springer-Verlag Italia s.r.l.",
number = "4",

}

TY - JOUR

T1 - Acute isolated ophthalmoplegia with anti-GQ1b antibodies

AU - Rigamonti, Andrea

AU - Lauria, Giuseppe

AU - Longoni, Marco

AU - Stanzani, Lorenzo

AU - Agostoni, Elio

PY - 2011/8

Y1 - 2011/8

N2 - Ophthalmoplegia without ataxia, areflexia or both has been designated as atypical Miller Fisher syndrome (MFS) or acute ophthalmoplegia (AO). This entity, first reported by Chiba et al. is associated with anti-GQ1b IgG antibodies.We report a patient with isolated acute ophthalmoplegia with high titer of anti-GQ1b IgG antibody activity in the acute phase in whom treatment with intravenous immunoglobulin (IVIg) led to the clinical recovery and the decrease in antibody titer.

AB - Ophthalmoplegia without ataxia, areflexia or both has been designated as atypical Miller Fisher syndrome (MFS) or acute ophthalmoplegia (AO). This entity, first reported by Chiba et al. is associated with anti-GQ1b IgG antibodies.We report a patient with isolated acute ophthalmoplegia with high titer of anti-GQ1b IgG antibody activity in the acute phase in whom treatment with intravenous immunoglobulin (IVIg) led to the clinical recovery and the decrease in antibody titer.

KW - Acute ophthalmoplegia

KW - GQ1b IgG antibodies

KW - Intravenous immunoglobulin

KW - Miller Fisher syndrome

UR - http://www.scopus.com/inward/record.url?scp=80053995306&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053995306&partnerID=8YFLogxK

U2 - 10.1007/s10072-011-0492-9

DO - 10.1007/s10072-011-0492-9

M3 - Article

C2 - 21336874

AN - SCOPUS:80053995306

VL - 32

SP - 681

EP - 682

JO - Neurological Sciences

JF - Neurological Sciences

SN - 1590-1874

IS - 4

ER -